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Background: Chemotherapy-induced alopecia (CIA) is one of the most distressing side effects for patients
undergoing chemotherapy. This study evaluated the protective effect of Korean Red Ginseng (KRG) on
CIA in a well-established in vitro human hair follicle organ culture model as it occurs in vivo.
Methods: We examined whether KRG can prevent premature hair follicle dystrophy in a human
hair follicle organ culture model during treatment with a key cyclophosphamide metabolite,
4-hydroperoxycyclophosphamide (4-HC).
Results: 4-HC inhibited human hair growth, induced premature catagen development, and inhibited
proliferation and stimulated apoptosis of hair matrix keratinocytes. In addition, 4-HC increased p53 and
Bax protein expression and decreased Bcl2 protein expression. Pretreatment with KRG protected against
4-HC-induced hair growth inhibition and premature catagen development. KRG also suppressed 4-HC-
induced inhibition of matrix keratinocyte proliferation and stimulation of matrix keratinocyte apoptosis.
Moreover, KRG restored 4-HC-induced p53 and Bax/Bcl2 expression.
Conclusion: Overall, our results indicate that KRG may protect against 4-HC-induced premature catagen
development through modulation of p53 and Bax/Bcl2 expression.
Copyright 2015, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hair provides protective, sensory, and sexual attractiveness
attributes and is also often used to indicate personal beliefs or
social position. During postnatal life, hair cyclically undergoes the
following three alternating phases of rapid growth: anagen (2e
6 yr), apoptosis-mediated regression (catagen, 2e3 wk), and
relative quiescence (telogen, 2e3 mo) [1]. Hair matrix keratino-
cytes at the anagen phase are some of the fastest dividing cells in
the body, with 60% of them remaining in the S phase [1]. Because
chemotherapeutic drugs target rapidly proliferating cell pop-
ulations, they attack not only neoplastic cancer cells but also
rapidly growing hair matrix keratinocytes in anagen, which leads
to hair loss (alopecia) [2].gy and Institute of Hair and Cosm
e).
rk.
ht 2015, The Korean Society of Gi
d/4.0/).Chemotherapy-induced alopecia (CIA) is one of the most dis-
tressing side effects for patients undergoing chemotherapy [3e5].
Although the CIA is almost always reversible, CIA can lead to
negative psychological perceptions for patients, even leading to
refusal of treatment [2,6]. The incidence of CIA is w65% among
patients receiving chemotherapy [5,7]. As much as 47e58% of fe-
male patients consider hair loss to be the most traumatic aspect of
chemotherapy and 8% would decline chemotherapy due to fears of
hair loss [8,9]. Therefore, the pursuit of more efﬁcient management
strategies for CIA remains a major research challenge in clinical
oncology [10].
Korean Red Ginseng (KRG; the steamed root of Panax ginseng
Meyer) has been an established traditional herbal medicine
for > 2,000 y [11]. KRG has been cultivated and aged for  4e6 yr,etic Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju,
nseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
Fig. 1. Follicular keratinocytes viability assay. Cell viability (%) ¼ (mean absorbency in
test wells)/(mean absorbency in control wells)  100. All the values are shown as
mean  standard deviation. * p < 0.05 versus control cells incubated with media alone.
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cesses to enhance its pharmacological activity and stability [12].
Recent studies have reported antitumor, antiviral, antidiabetic,
antioxidative, and immune-modulatory activities of KRG [13e16].
Furthermore, a number of studies have also illustrated the role of
KRG as a potent regulator of hair growth. KRG prevents apoptosis of
hair follicles in irradiated mice, promotes hair growth in C57BL/6
mice, promotes human and murine vibrissae hair growth in organ
culture, and improves hair regrowth in androgenetic alopecia and
alopecia areata patients [17e21].
In a recently developed in vitro human hair follicle organ culture
model for CIA, the cyclophosphamide (chemotherapeutic drug)
metabolite 4-hydroperoxycyclophosphamide (4-HC) induces
apoptosis followed by dystrophy in isolated human anagen hair
follicles, like CIA in vivo [22]. This study assessed the ability of KRG
to protect against CIA in a well-established in vitro human hair
follicle organ culture model [22].
2. Materials and methods
2.1. Materials
The KRG extract was provided by the Korea Ginseng Corporation
(Daejeon, Korea) through a standardized and reproducible process.
The extract was manufactured by the Korea Ginseng Corporation
(Seoul, Korea) from the roots of a 6-y-old red ginseng (P. ginseng
Meyer), which was harvested in the Korea. KRG was prepared by
steaming fresh ginseng at 90e100C for 3 h and then drying it at
50e80C. The KRG extract was prepared from red ginseng water
extract, which was extracted three times at 85e90C for 8 h in
circulating hot water. The water content of the pooled extract was
36% of the total weight. KRG was analyzed by HPLC and contained
the following major ginsenosides (Rb1, 7.44 mg/g; Rb2, 2.59 mg/g;
Rc, 3.04 mg/g; Rd, 0.91 mg/g; Re, 1.86 mg/g; Rf, 1.24 mg/g; Rg1, 1.79
mg/g; Rg2, 1.24 mg/g; and Rg3, 1.39 mg/g) and other minor
ginsenosides.
The key cyclophosphamide metabolite 4-HC was purchased
from Niomec (Bielefeld, Germany).
2.2. Isolation and culture of follicular keratinocytes
Human occipital scalp skin specimens were obtained from pa-
tients undergoing hair transplantation surgery after obtaining
informed consent. The Institutional Ethics Committee of the Yonsei
University, Wonju College of Medicine, Wonju, Korea, approved all
described studies. The study was conducted according to the
principles of the Declaration of Helsinki.
For culture of follicular keratinocytes (FKCs), anagen hair follicles
were cut off from the hair bulb region and then dermal sheathes
were removed from the upper part of the hair follicles. Hair shafts,
including part of the outer root sheath, were treated with 0.05%
trypsineEDTA (Invitrogen, Waltham, Massachusetts, USA). The
dissociated cells were rinsed in Dulbecco’s Modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum and centrifuged for
5 min at 1,500 rpm. Cells were then resuspended in EpiLife medium
(Cascade Biologics, Portland, OR, USA) with EpiLife deﬁned growth
supplement (Cascade Biologics) and antibiotics and seeded onto a
culture dish. Second-passage FKCs were used in this study.
2.3. Cell viability assay
The cytotoxic effects of KRG on FKCs were determined by MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
assay [23]. In brief,1104 cells were seeded in eachwell containing
100 mL of the growth medium in a 96-well plate. Cells werepermitted to adhere for 24 h, and then were treated with serial
doses of KRG extract (from 0 mg/mL to 1,000 mg/mL) for 1e2 d. After
treatment, the medium in each well was removed and replaced
with a phosphate-buffered saline solution containing 5 mg/mL
MTT. Then the plate was incubated at 37C for 4 h. The remaining
supernatant was then completely removed and 100 mL of dimethyl
sulfoxide was added to each well and mixed thoroughly to dissolve
the crystallized formazan. After 10 min of incubation to ensure that
all formazan crystals were dissolved, the optical density at 570 nm
was determined using an enzyme-linked immunosorbent assay
reader. The mean absorbance of the treated groupwas expressed as
the cell viability percentage of the control group’s absorbance.
Three repeated experiments were performed.
2.4. Human hair follicle organ culture
Human anagen hair follicles were isolated as previously
described [24]. Isolated human anagen hair follicles were main-
tained in Williams E medium (Invitrogen) supplemented with
10 mg/mL insulin (Sigma, St. Louis, MO, USA), 10 ng/mL hydrocor-
tisone (Sigma), 2mM L-glutamine (Invitrogen), 100 IU/mL penicillin,
and 100 mg/mL streptomycin (Invitrogen) for 1 d. Isolated anagen
hair follicles were cultured in each type of medium for 6 d. In brief,
control hair follicles were cultured with vehicle for 6 d. Test groups
were pretreated with or without KRG (100 mg/mL or 500 mg/mL) on
Day 0. Furthermore, a key cyclophosphamide (chemotherapeutic
drug) metabolite, 4-HC (20mM), was added on Day 1 [22]. Western
blot analysis and immunoﬂuorescence staining were performed
after 2 d of culture. The same experiment was repeated three times.
2.5. Measurement of hair follicle length and morphology
The hair follicle length was deﬁned as the entire length from the
base of the hair bulb to the tip of the hair shaft. Measurements were
made every 2 d using the measuring scales attached to the objec-
tive lens of the microscope until the 6th d of cultivation. The
measured values were then statistically analyzed. At the same time,
the hair follicle morphology (anagen, early catagen, mid catagen,
and late catagen) was observed and the hair cycle score was
measured according to the following system: anagen VI, 100; early
catagen, 200; mid catagen, 300; and late catagen 400. Experiments
were repeated three times.
Fig. 2. Protective effects of Korean Red Ginseng (KRG) on 4-hydroperoxy-
cyclophosphamide (4-HC)-induced human hair growth inhibition. Human hair folli-
cles were treated with 4-HC alone or 4-HC plus KRG for 6 d. Hair length was measured
every 2nd d. All the values are the mean  standard deviation. *p < 0.05 and **p < 0.01,
respectively.
Fig. 3. Protective effects of Korean Red Ginseng (KRG) on 4-hydroperoxycyclophosphamid
with 4-HC alone or 4-HC plus KRG for 6 d. For statistical analysis, anagen VI hair follicle unit
catagen stages were assigned scores of 200, 300, and 400, respectively. The sum of each ha
Analysis of hair cycle staging of each hair follicle (anagen, early catagen, mid catagen, and la
stage of each hair follicle was assessed and classiﬁed as previously described [26,27]. In brief,
hair bulb and a narrow and elongated dermal papilla. Early catagen shows a narrow hair b
sumptive club just above the dermal papilla. Late catagen shows a narrower epithelial stran
**p < 0.01. DP, dermal papilla; ES, epithelial strand.
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For immunoﬂuorescence staining of Ki-67, after deparafﬁniza-
tion and rehydration, sections were ﬁxed with 4% para-
formaldehyde (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
containing 0.1% Triton X-100 (Sigma) for 10 min and equilibrated in
phosphate-buffered saline for 15 min at room temperature. After
blocking with 4% normal donkey serum, sections were incubated
with mouse monoclonal Ki-67 antibody (Abcam, Cambridge, MA,
USA) and then incubated again with Alexa Fluor 488-labeled
donkey antimouse secondary antibody (Invitrogen). Fluorescent
specimens were analyzed with a TCS SPE confocal microscope
(Leica Microsystems, Bannockburn, IL, USA).
To evaluate apoptotic cells in hair follicles, terminal deoxy-
nucleotidyl transferase-mediated 20-deoxyuridine 50-triphosphate-
biotin nick-end labeling (TUNEL) was performed using the ApopTag
Plus peroxidase in situ apoptosis detection kit (Chemicon, Billerica,
MA, USA) according to the manufacturer’s instructions. In brief,
parafﬁn sections were digested with 20 mg/mL of proteinase K for
15 min at room temperature and treated with terminal deoxy-
nucleotidyl transferase for 60 min at 37C. TUNEL-positive cells
were visualized by an antidigoxigenin ﬂuorescein antibody.e (4-HC)-induced premature catagen development. Human hair follicles were treated
s were assigned a score of 100, and hair follicle units in the early catagen, mid, and late
ir follicle score was then divided by the number of investigated hair follicle units. (A)
te catagen). (B) Calculation of the hair cycle score of each hair follicle. (C) The hair cycle
anagen VI (fully developed terminative hair follicles) shows a prominent onion-shaped
ulb, fully opened at the proximal end. Mid catagen shows a partially keratinized pre-
d. All the values are the mean  standard deviation. Scale bar ¼ 100 mm. *p < 0.05 and
J Ginseng Res 2016;40:169e175172Sections were then counterstained with propidium iodide and
visualized on a Leica TCS SPE confocal microscope. The same ex-
periments were repeated three times.
2.7. Western blot analysis
Whole-hair-follicle extracts were isolated using a protein prep
kit (Qiagen, Hilden, Germany), incubated for 30 min on ice, and
then centrifuged at 12,000 rpm for 10 min to remove any insoluble
material. Protein concentration was measured using the Bradford
method. Proteins were separated by sodium dodecyl sulfatee
polyacrylamide gel electrophoresis using a 10% acrylamide gel and
then transferred to a polyvinylidene diﬂuoridemembrane (Bio-Rad,
Hercules, CA, USA). The membrane was blocked with Tris-buffered
saline/Tween-20 containing 5% skim milk for 1 h, incubated over-
night with primary antibodies against p53 (Abcam), Bax, Bcl2
(Santa Cruz Biotechnology), and b-actin (Sigma), and then incu-
bated with horseradish-peroxidase-conjugated secondary anti-
bodies. Protein expression was visualized by enhanced
chemiluminescence Western blot detection reagents (Santa Cruz
Biotechnology). Experiments were repeated three times.
2.8. Statistical analysis
Data handling and drawing were processed using the SPSS
version 20.0 for Windows (SPSS Inc., Chicago, IL, USA). Statistical
analysis was performed using one-way analysis of variance fol-
lowed by Dunnett multiple comparison tests to compare three or
more groups. The Student t test was used to compare two differentFig. 4. Pretreatment with Korean Red Ginseng (KRG) increases cell proliferation and decreas
(DeF) immunodetection of apoptotic cells [terminal deoxynucleotidyl transferase-mediated
the hair bulb region were analyzed. All the values are the mean  standard deviation. Scalgroups. A p value < 0.05 was considered statistically signiﬁcant. All
data are presented as the mean  standard deviation of at least
three separate experiments.
3. Results
3.1. Cytotoxic effects of KRG on FKCs viability
Human FKCs were treated with a serial dose (from 0 mg/mL to
1,000 mg/mL) of KRG extract and its cytotoxic effects were exam-
ined. Based on careful titration studies, KRG was found not to affect
cell survival or show any signiﬁcant toxic effect on the FKCs up to a
concentration of 500 mg/mL (Fig. 1). The KRG extract, however,
showed cytotoxic effects at 1,000 mg/mL (p < 0.05; Fig. 1).
3.2. KRG reduces 4-HC-induced hair growth inhibition
As a key cyclophosphamide (chemotherapeutic drug) metabo-
lite, 4-HC has been known to produce CIA-like pathogenesis in hair
follicle organ culture systems, similar to its in vivo effects [22].
We examined the potential involvement of KRG on 4-HC-
induced hair growth inhibition. Hair follicles were incubated with
4-HC alone or with 20mM 4-HC plus KRG extract for 6 d. When
human cells were treated with 20mM 4-HC, hair follicle length was
signiﬁcantly reduced after 2 d of culture (p < 0.05; Fig. 2). Pre-
treatment with 500 mg/mL KRG signiﬁcantly suppressed 4-HC-
induced hair growth inhibition after 4 d of culture. By contrast,
pretreatment with 100 mg/mL KRG did not suppress 4-HC-induced
hair growth inhibition (Fig. 2).es apoptosis in the hair bulb region. (AeC) Proliferating (Ki-67 positive, green) cells and
20-deoxyuridine 50-triphosphate-biotin nick-end labeling (TUNEL) positive, green] in
e bar ¼ 100 mm. *p < 0.05. Abbreviation4-HC, 4-hydroperoxycyclophosphamide.
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development
To evaluate whether KRG affects the 4-HC-induced premature
catagen-like transformation [22,25], histological morphology of
hair follicle was assessed and the hair cycle score was calculated as
described previously [26,27]. As shown in Fig. 3, only 4% of hair
follicles remained in anagen, and > 90% had already approached
catagen (14% in early catagen, 46% in mid catagen, and 36% in late
catagen; Fig. 3A). Pretreatment with 500 mg/mL KRG signiﬁcantly
(p < 0.05) reduced 4-HC-induced premature catagen development
(14% in anagen, 48% in early catagen, 28% inmid catagen, and 10% in
late catagen; Fig. 3A). This was conﬁrmed by calculation of the hair
cycle score. Hair cycle scorewas signiﬁcantly (p< 0.05) increased in
the 4-HC-treated hair follicles compared with vehicle controls. The
hair cycle score was signiﬁcantly reduced (p < 0.05) in the KRG-
pretreated hair follicle units compared with hair follicles treated
with 4-HC alone (Fig. 3B). Approximately 20mM 4-HC accelerated
catagen-like regressive development, which was characterized by
the upward movement of the hair from the dermal papilla [28,29]
(Fig. 3C).
3.4. KRG suppresses 4-HC-induced inhibition of matrix keratinocyte
proliferation and stimulation of matrix keratinocyte apoptosis
Chemotherapeutic drugs target rapidly proliferating cell pop-
ulations, such as hair follicles, leading to massive apoptosis in hair
matrix keratinocytes, followed by hair loss [10,30e32]. Quantita-
tive evaluation of proliferating (Ki-67 positive) and apoptoticFig. 5. Effects of 4-hydroperoxycyclophosphamide (4-HC) alone or 4-HC plus Korean Red Gin
were pretreated with or without KRG (100 mg/mL or 500 mg/mL) on Day 0, and were then tre
with 4-HC), Western blot analysis was performed. HC treatment signiﬁcantly increased the
values are the mean  standard deviation. *p < 0.05.(TUNEL positive) hair follicle cells showed that 4-HC signiﬁcantly
(p < 0.05) decreases Ki-67-positive cells and increases TUNEL-
positive cells in the hair bulb region. Furthermore, pretreatment
with KRG signiﬁcantly (p < 0.05) suppressed 4-HC-induced inhi-
bition of matrix keratinocyte proliferation and stimulation of ma-
trix keratinocyte apoptosis (Fig. 4).
3.5. KRG decreases p53 and proapoptotic Bax expression and
increases antiapoptotic Bcl2 expression
The signaling pathways leading to apoptosis of matrix kerati-
nocytes include p53, Bax, Bcl2, and others [10,33]. To determine
whether KRG extract affects the expression of various factors
related to apoptosis, Western blot analysis was performed. The 4-
HC treatment signiﬁcantly increased the expression of p53 and
Bax proteins, and decreased Bcl2 expression (p < 0.05). Pretreat-
ment with KRG signiﬁcantly inhibited the expression of these
proteins (p < 0.05; Fig. 5).
4. Discussion
CIA is one of the most distressing side effects for patients un-
dergoing chemotherapy. The incidence of CIA is w65% among pa-
tients undergoing chemotherapy [5,7]. However, no efﬁcient
preventative pharmacological regimen for CIA has been established
to date. Previous research on CIA has been hampered due to a lack
of appropriate experimental models that correlate with human
tissues [34]. In a recently developed in vitro human hair follicle
organ culture model for CIA, it was shown that 4-HC inducesseng (KRG) on the expression of p53, Bcl2, and Bax in human hair follicles. Hair follicles
ated with 20mM 4-HC on Day 1. After being cultured for 2 d (i.e., after 1 d of treatment
expression of p53 (A) and Bax proteins (B), and decreased Bcl2 expression (C). All the
J Ginseng Res 2016;40:169e175174apoptosis and then dystrophy in isolated human anagen hair fol-
licles. This is similar to what happens in CIA in vivo and shows
characteristic signs such as reduced proliferation and increased
apoptosis of hair matrix keratinocytes, hair growth inhibition, and
premature catagen induction [22,34,35].
KRG is a dietary ingredient that has been used by humans for a
long time. Increasing evidence suggests that KRG is a potent
regulator of hair growth [17e21]. Furthermore, KRG can protect
against side effects of chemotherapy and radiotherapy [36e40].
Here, we used an in vitro human hair follicle organ culture model
for CIA [22] to examinewhether KRG can protect against premature
catagen development in response to a key cyclophosphamide
metabolite, 4-HC. We also investigated possible mechanisms of
protection. This study showed that 4-HC inhibited human hair
growth and induced premature catagen development. 4-HC
inhibited proliferation and stimulated apoptosis of hair matrix
keratinocytes and increased p53 and Bax protein expression while
decreasing Bcl2 protein expression. Pretreatment with KRG had a
protective effect on 4-HC-induced hair growth inhibition and pre-
mature catagen development. In addition, 4-HC-induced inhibition
of matrix keratinocyte proliferation and stimulation of matrix
keratinocyte apoptosis were successfully suppressed. Moreover,
KRG restored 4-HC-induced p53 and Bax/Bcl2 expression.
Activated hair bulb keratinocytes are rapidly proliferating cells
and their proliferation is an important event for anagen hair
growth. Because chemotherapeutic drugs can directly damage
rapidly dividing cells, hair matrix keratinocytes are vulnerable to
chemotherapy [41,42]. In a human hair follicle organ culture model
for CIA, KRG protects against premature catagen development and
suppresses 4-HC-induced inhibition of matrix keratinocyte prolif-
eration and stimulation of matrix keratinocyte apoptosis. This in-
dicates that the protective effects of KRG on CIA may be mediated
through the improvement of hair matrix cell survival.
p53-dependent apoptosis of hair matrix keratinocytes plays a
central role in CIA pathogenesis [10]. It has been reported that p53-
deﬁcient mice do not show hair loss or apoptosis of keratinocytes
after cyclophosphamide administration [43,44], and these obser-
vations also led to the evaluation of inhibitors of p53 signaling for
treating CIA [45]. p53 is activated by external and internal stress
signals that promote its nuclear accumulation in an active form,
inducing either viable cell growth arrest or apoptosis [46].
Transcription-independent p53 activity is involved in many cell
death processes and is associated with cytoplasmic or mitochon-
drial proteins, including members of the Bcl2 family [47e49]. The
Bcl2 family is classiﬁed into three classes, namely, antiapoptotic
proteins (e.g., Bcl2), proapoptotic proteins (e.g., Bax and Bak), and
proapoptotic “BH3-only” proteins [46,50]. In this study, KRG
recovered 4-HC-induced p53 and Bax/Bcl2 expression, indicating
that the protective effects of KRG on 4-HC-induced CIA occur at
least in part through modulation of p53 and Bax/Bcl2 expression.
In conclusion, KRG may protect against 4-HC-induced prema-
ture dystrophy as it occurs in CIA in vivo. Possible mechanisms
include the stimulation of hair matrix keratinocyte proliferation
and inhibition of hair matrix keratinocyte apoptosis, which are
possibly mediated through modulation of p53 and Bax/Bcl2
expression.
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